Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by fivenineron Mar 03, 2017 7:29pm
176 Views
Post# 25930302

RE:News

RE:News As I said yesterday, Skidmore has always been cagey with being a 10% insider. No dobt he sold it down to just under the 10% limit. Melanie Skidmore is still a reporting 10% insider.

BRIAN DAVID SKIDMORE
21476 76 Avenue Langley, BC Canada, V2Y 2E8

FOR IMMEDIATE RELEASE: SHAREHOLDER NEWS RELEASE Vancouver, Canada – March 3, 2017 – Brian David Skidmore issues this early warning news release in respect of his securityholdings of Ventripoint Diagnostics Ltd. (TSXV: VPT) (the “Issuer”). On March 2, 2017, Mr. Skidmore sold 2,000,000 common shares of the Issuer (the “Shares”) through the TSX Venture Exchange at a price of $0.14 per share. The Shares represent approximately 6.2% of Issuer’s current issued and outstanding common shares.

As a result of the sale of the Shares, Mr. Skidmore holds or exercises shared control or direction over a total of 2,615,347 common shares of the Issuer, representing approximately 8.1% of the current issued and outstanding shares of the Issuer and share purchase warrants to purchase 500,000 common shares of the Issuer. Assuming the exercise in full of the share purchase warrants, the number of common shares held by Mr. Skidmore or over which he exercised shared control or direction represents approximately 9.7% of the current issued and outstanding common shares of the Issuer.

This news release is being disseminated pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues (“NI 62-103”). A copy of the report to be filed with Canadian securities regulators in connection with the acquisition of these securities can be obtained upon its filing under the Issuer’s profile on the SEDAR website (www.SEDAR.com) or by contacting Ron Paton of Owen Bird Law Corporation at 604 691 7504.
Bullboard Posts